David R. Andes, MD close
David R. Andes, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

David R. Andes, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Andes’ clinical interests include general infectious diseases, transplant infectious diseases, mycology, antimicrobial pharmacokinetics and pharmacodynamics. 


Infectious Diseases

Travel Medicine


University Hospital
(608) 263-0946 | (800) 323-8942 | Map
University Hospital
(608) 890-6167 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Infectious Diseases
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Missouri School of Medicine, Columbia, MO

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

The overriding themes of our research programs are to advance our understanding of antibacterial and antifungal activity and drug resistance, and to identify new antimicrobial drug treatment strategies and drug targets.

PubMed Articles
Zarnowski R Sanchez H Andreu C Andes D Del Olmo ML Formation and characterization of biofilms formed by salt-tolerant yeast strains in seawater-based growth medium. Appl Microbiol Biotechnol . 2021 Feb 25;
[PubMed ID: 33630153]
O'Beirne C Piatek ME Fossen J Müller-Bunz H Andes DR Kavanagh K Patil SA Baumann M Tacke M Continuous flow synthesis and antimicrobial evaluation of NHC* silver carboxylate derivatives of SBC3 in vitro and in vivo. Metallomics . 2021 Feb 17;13(2)
[PubMed ID: 33595656]
Bae M Mevers E Pishchany G Whaley SG Rock CO Andes DR Currie CR Pupo MT Clardy J Chemical Exchanges between Multilateral Symbionts. Org Lett . 2021 Feb 16;
[PubMed ID: 33591189]
Rayner CR Smith PF Andes D Andrews K Derendorf H Friberg LE Hanna D Lepak A Mills E Polasek TM Roberts JA Schuck V Shelton MJ Wesche D Rowland-Yeo K Model-Informed Drug Development for Anti-Infectives: State of the Art and Future. Clin Pharmacol Ther . 2021 Feb 8;
[PubMed ID: 33555032]
Ye M Zhao Y Wang Y Zhao M Yodsanit N Xie R Andes D Gong S A Dual-Responsive Antibiotic-Loaded Nanoparticle Specifically Binds Pathogens and Overcomes Antimicrobial-Resistant Infections. Adv Mater . 2021 Jan 22;:e2006772
[PubMed ID: 33480454]
Beredaki MI Arendrup MC Andes D Mouton JW Meletiadis J The Role of New Posaconazole Formulations in the Treatment of <i>Candida albicans</i> Infections:Data from an <i>in Vitro</i> Pharmacokinetic-Pharmacodynamic Model. Antimicrob Agents Chemother . 2021 Jan 19;
[PubMed ID: 33468486]
Sircaik S Román E Bapat P Lee KK Andes DR Gow NAR Nobile CJ Pla J Panwar SL The protein kinase Ire1 impacts pathogenicity of Candida albicans by regulating homeostatic adaptation to endoplasmic reticulum stress. Cell Microbiol . 2021 Jan 5;:e13307
[PubMed ID: 33403715]
Vanamala K Tatiparti K Bhise K Sau S Scheetz MH Rybak MJ Andes D Iyer AK Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance. Drug Discov Today . 2021 Jan;26(1):31-43
[PubMed ID: 33091564]
Zhao M Zhang F Zarnowski R Barns KJ Jones R Fossen JL Sanchez H Rajski SR Audhya A Bugni TS Andes DR Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking. J Clin Invest . 2020 Dec 29;
[PubMed ID: 33373326]
Zarnowski R Jaromin A Zagórska A Dominguez EG Sidoryk K Gubernator J Andes DR A Label-Free Cellular Proteomics Approach to Decipher the Antifungal Action of DiMIQ, a Potent Indolo[2,3-<i>b</i>]Quinoline Agent, against <i>Candida albicans</i> Biofilms. Int J Mol Sci . 2020 Dec 24;22(1)
[PubMed ID: 33374351]
Iyer KR Camara K Daniel-Ivad M Trilles R Pimentel-Elardo SM Fossen JL Marchillo K Liu Z Singh S Muñoz JF Kim SH Porco JA Jr Cuomo CA Williams NS Ibrahim AS Edwards JE Jr Andes DR Nodwell JR Brown LE Whitesell L Robbins N Cowen LE An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris. Nat Commun . 2020 Dec 22;11(1):6429
[PubMed ID: 33353950]
Li H Sun CY Fang Y Carlson CM Xu H Ješovnik A Sosa-Calvo J Zarnowski R Bechtel HA Fournelle JH Andes DR Schultz TR Gilbert PUPA Currie CR Biomineral armor in leaf-cutter ants. Nat Commun . 2020 Nov 24;11(1):5792
[PubMed ID: 33235196]
Zhang F Zhao M Braun DR Ericksen SS Piotrowski JS Nelson J Peng J Ananiev GE Chanana S Barns K Fossen J Sanchez H Chevrette MG Guzei IA Zhao C Guo L Tang W Currie CR Rajski SR Audhya A Andes DR Bugni TS A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science . 2020 Nov 20;370(6519):974-978
[PubMed ID: 33214279]
Andes D Candidemia in the Growing Opioid Epidemic: A Distinct and Emerging Entity. Clin Infect Dis . 2020 Oct 23;71(7):1738-1740
[PubMed ID: 31676896]
Lepak AJ Wang W Andes DR Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative Pathogens. Antimicrob Agents Chemother . 2020 Oct 20;64(11)
[PubMed ID: 32868332]
McCreary EK Nguyen MH Davis MR Borlagdan J Shields RK Anderson AD Rivosecchi RM Marini RV Sacha LM Silveira FP Andes DR Lepak AJ Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tube. J Antimicrob Chemother . 2020 Oct 1;75(10):3023-3028
[PubMed ID: 32710097]
Donnelly JP Chen SC Kauffman CA Steinbach WJ Baddley JW Verweij PE Clancy CJ Wingard JR Lockhart SR Groll AH Sorrell TC Bassetti M Akan H Alexander BD Andes D Azoulay E Bialek R Bradsher RW Bretagne S Calandra T Caliendo AM Castagnola E Cruciani M Cuenca-Estrella M Decker CF Desai SR Fisher B Harrison T Heussel CP Jensen HE Kibbler CC Kontoyiannis DP Kullberg BJ Lagrou K Lamoth F Lehrnbecher T Loeffler J Lortholary O Maertens J Marchetti O Marr KA Masur H Meis JF Morrisey CO Nucci M Ostrosky-Zeichner L Pagano L Patterson TF Perfect JR Racil Z Roilides E Ruhnke M Prokop CS Shoham S Slavin MA Stevens DA Thompson GR Vazquez JA Viscoli C Walsh TJ Warris A Wheat LJ White PL Zaoutis TE Pappas PG Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis . 2020 Sep 12;71(6):1367-1376
[PubMed ID: 31802125]
Johnson MD Lewis RE Dodds Ashley ES Ostrosky-Zeichner L Zaoutis T Thompson GR Andes DR Walsh TJ Pappas PG Cornely OA Perfect JR Kontoyiannis DP Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. J Infect Dis . 2020 Aug 5;222(Supplement_3):S175-S198
[PubMed ID: 32756879]
Rodríguez López AL Lee MR Wang NB Dunn KK Sanchez H Raman N Andes DR Lynn DM Palecek SP Correction for Rodríguez López et al., "Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation". Antimicrob Agents Chemother . 2020 Jun 23;64(7)
[PubMed ID: 32576596]
Thomas CS Braun DR Olmos JL Jr Rajski SR Phillips GN Jr Andes D Bugni TS Pyridine-2,6-Dithiocarboxylic Acid and Its Metal Complexes: New Inhibitors of New Delhi Metallo β-Lactamase-1. Mar Drugs . 2020 Jun 2;18(6)
[PubMed ID: 32498259]